B

Brainsway Ltd
TASE:BWAY

Watchlist Manager
Brainsway Ltd
TASE:BWAY
Watchlist
Price: 1 808 ILS -2.53% Market Closed
Market Cap: 594m ILS
Have any thoughts about
Brainsway Ltd?
Write Note

Brainsway Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Brainsway Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
B
Brainsway Ltd
TASE:BWAY
Cash from Financing Activities
-$1m
CAGR 3-Years
0%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
Nano-X Imaging Ltd
NASDAQ:NNOX
Cash from Financing Activities
$27.3m
CAGR 3-Years
-52%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Inmode Ltd
NASDAQ:INMD
Cash from Financing Activities
-$164m
CAGR 3-Years
-177%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Cash from Financing Activities
-$18.8m
CAGR 3-Years
-14%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Cash from Financing Activities
-$1.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Epitomee Medical Ltd
TASE:EPIT
Cash from Financing Activities
-$454k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Brainsway Ltd
Glance View

Market Cap
594m ILS
Industry
Health Care

Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

BWAY Intrinsic Value
2 162.45 ILS
Undervaluation 16%
Intrinsic Value
Price
B

See Also

What is Brainsway Ltd's Cash from Financing Activities?
Cash from Financing Activities
-1m USD

Based on the financial report for Dec 31, 2023, Brainsway Ltd's Cash from Financing Activities amounts to -1m USD.

What is Brainsway Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-31%

Over the last year, the Cash from Financing Activities growth was 34%.

Back to Top